Owkin

Executive Summary

Paris-based Owkin is a federated-learning AI biotech that partners with Sanofi and BMS to accelerate drug discovery. Utilizing AI to glean insights from vast, decentralized datasets, Owkin aims to overcome data silos and enhance research collaborations. This specialized approach positions them to capitalize on the increasing demand for AI-driven solutions in pharmaceuticals, a market sector experiencing rapid growth. Owkin is a leading player in this niche, driving innovation to improve patient care and drug development timelines.